https://www.pharmanow.live/latest-news/viatris-acquires-pacira-biosciences-regulatory-approvals-innovative-medicines-pivot 2026-11-06T09:44:41+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Viatris Acquires Pacira BioSciences as Regulatory Approvals Accelerate Innovative Medicines Pivot Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://newsroom.viatris.com/file.php/181193/Refreshed_Viatris_Logo_thumb.png?thumbnail=144 https://www.pharmanow.live/latest-news/telix-pharmaceuticals-joins-thera4care-consortium-tlx400-tx-fap-targeting-theranostics-europe 2026-11-06T09:41:08+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Telix Pharmaceuticals Joins Thera4Care Consortium for Terbium-161 Theranostics Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/dbf2b98e-d76f-4832-99b6-23419b0b67c7/82902f57-9a72-46ed-b467-a4ab1398303a.png https://www.pharmanow.live/latest-news/bayer-gains-china-first-line-approval-sevabertinib-her2-mutated-advanced-lung-cancer 2026-11-06T09:42:26+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Bayer Gains China First-Line Approval for Sevabertinib in Advanced Lung Cancer Bayer https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/dbf2b98e-d76f-4832-99b6-23419b0b67c7/12db056e-afe5-4968-91b9-49c8e7882a3a.png https://www.pharmanow.live/latest-news/evotec-secures-vertex-commercial-manufacturing-deal-povetacicept-jpod-redmond 2026-11-06T09:35:35+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Evotec Secures Vertex Commercial Manufacturing Deal for Povetacicept Evotec https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/dbf2b98e-d76f-4832-99b6-23419b0b67c7/0b8abbc6-4bd7-4ce1-b45f-bdfc55bccb9a.png https://www.pharmanow.live/latest-news/alembic-pharma-difgen-partnership-us-complex-generics 2026-11-06T09:34:38+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Alembic Pharma Signs Deal with DifGen to Accelerate US Complex Generics Approvals Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/7c5d1dfe-e838-4e75-86a8-8e6ada7c19f5/834f9623-24da-4f54-8c0f-0163303f5a87.png https://www.pharmanow.live/latest-news/fresenius-wuxi-biologics-deal-biosimilar-pipeline-66-molecules 2026-11-06T12:00:57+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Fresenius Teams With WuXi on 66-Molecule Biosimilar Pipeline Fresenius https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fresenius-wuxi-biologics-biosimilar-pipeline-66-molecules-202620261106120048.webp https://www.pharmanow.live/latest-news/oryzon-iadademstat-phase-ib-aml-ash-2026-phase-iii-pivot 2026-11-06T11:48:44+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Oryzon Reports 95% ORR in Phase Ib AML Trial Ahead of Phase III Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-iadademstat-95-percent-orr-phase-ib-aml-trial-ash-202620261106114821.webp https://www.pharmanow.live/latest-news/merck-launches-phase-3-trial-ohtuvayre-copd-exacerbations 2026-11-06T11:43:43+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Merck Launches Phase 3 OHTUVAYRE Trial for COPD Exacerbations Merck https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/merck-ohtuvayre-enhance-3-phase-3-copd-exacerbation-trial-202620261106114120.webp https://www.pharmanow.live/latest-news/medicus-pharma-spac-loi-skinject-135-million-business-combination 2026-11-06T11:34:32+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Medicus Proposes $135M SkinJect Business Combination With SPAC Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/medicus-pharma-skinject-135-million-spac-business-combination-202620261106112654.webp